Timentin

Timentin is a brand name of clavulanate/ticarcillin, approved by the FDA in the following formulation(s):

TIMENTIN (clavulanate potassium; ticarcillin disodium - injectable; injection)

• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: April 1, 1985
  
  Strength(s): EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL ^[RLD], EQ 200MG BASE/VIAL;EQ 3GM BASE/VIAL ^[RLD]


• 
  Manufacturer: GLAXOSMITHKLINE
  
  Approval date: August 18, 1987
  
  Strength(s): EQ 1GM BASE/VIAL;EQ 30GM BASE/VIAL ^[RLD]

Has a generic version of Timentin been approved?

No. There is currently no therapeutically equivalent version of Timentin available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Timentin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Timentin.

See also...

• Timentin Consumer Information (Wolters Kluwer)
• Timentin injection Consumer Information (Cerner Multum)
• Timentin Advanced Consumer Information (Micromedex)
• Timentin Novaplus Advanced Consumer Information (Micromedex)
• Timentin AHFS DI Monographs (ASHP)
• Ticarcillin/Clavulanate Consumer Information (Wolters Kluwer)
• Ticarcillin and clavulanate potassium injection Consumer Information (Cerner Multum)
• Ticarcillin and clavulanate Intravenous Advanced Consumer Information (Micromedex)
• Ticarcillin Disodium and Clavulanate Potassium AHFS DI Monographs (ASHP)